CCIA
UTHR icon

Campbell & Co Investment Adviser’s United Therapeutics UTHR Stock Holding History

Campbell & Co Investment Adviser’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.82M Buy
+6,434
New +$3.2M 0.22% 125
2025
Q3 		– Sell
-4,140
Closed -$1.19M – 1398
2025
Q2 		$1.19M Sell
4,140
-3,362
-45% -$1M 0.08% 429
2025
Q1 		$2.31M Buy
+7,502
New +$2.57M 0.18% 154
2024
Q4 		– Sell
-1,043
Closed -$374K – 1389
2024
Q3 		$374K Buy
+1,043
New +$352K 0.03% 825
2024
Q2 		– Sell
-5,932
Closed -$1.36M – 1365
2024
Q1 		$1.36M Sell
5,932
-2,313
-28% -$522K 0.12% 269
2023
Q4 		$1.81M Buy
8,245
+5,120
+164% +$1.18M 0.16% 164
2023
Q3 		$706K Buy
3,125
+1,678
+116% +$386K 0.08% 390
2023
Q2 		$319K Sell
1,447
-9,071
-86% -$2.01M 0.06% 633
2023
Q1 		$2.36M Buy
10,518
+3,974
+61% +$980K 0.44% 12
2022
Q4 		$1.82M Buy
+6,544
New +$1.65M 0.44% 12
2022
Q3 		– Sell
-7,835
Closed -$1.85M – 951
2022
Q2 		$1.85M Buy
7,835
+6,127
+359% +$1.25M 0.5% 16
2022
Q1 		$306K Buy
1,708
+366
+27% +$69.7K 0.08% 473
2021
Q4 		$290K Sell
1,342
-1,500
-53% -$294K 0.1% 370
2021
Q3 		$525K Buy
+2,842
New +$560K 0.17% 200
2021
Q2 		– Sell
-1,292
Closed -$216K – 724
2021
Q1 		$216K Sell
1,292
-418
-24% -$69.7K 0.13% 335
2020
Q4 		$260K Sell
1,710
-600
-26% -$78.7K 0.16% 280
2020
Q3 		$233K Sell
2,310
-2,355
-50% -$258K 0.17% 269
2020
Q2 		$564K Buy
+4,665
New +$525K 0.71% 14
2018
Q4 		– Sell
-1,794
Closed -$229K – 514
2018
Q3 		$229K Buy
+1,794
New +$222K 0.16% 304
2017
Q2 		– Sell
-1,504
Closed -$204K – 373
2017
Q1 		$204K Buy
+1,504
New +$228K 0.53% 108
2014
Q3 		– Sell
-16,907
Closed -$1.5M – 254
2014
Q2 		$1.5M Buy
+16,907
New +$1.63M 0.6% 71
2014
Q1 		– Sell
-6,900
Closed -$780K – 304
2013
Q4 		$780K Buy
+6,900
New +$622K 0.18% 138

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Campbell & Co Investment Adviser's UTHR Position: Q1 2026 in Review

Campbell & Co Investment Adviser opened a new position in United Therapeutics (UTHR) in Q1 2026: 6,434 shares worth $3.82M. The stake represents 0.22% of the portfolio and ranks #125 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in UTHR as recently as Q2 2025.

Campbell & Co Investment Adviser first reported a position in UTHR in Q4 2013 and has held it in 22 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Campbell & Co Investment Adviser held 6,434 shares of United Therapeutics worth $3.82M as of Q1 2026.
  • United Therapeutics was a new Campbell & Co Investment Adviser position in Q1 2026.
  • United Therapeutics made up 0.22% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #125 holding.
  • Campbell & Co Investment Adviser first reported a position in United Therapeutics in Q4 2013 and has held it in 22 quarters since.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.